1. NOV-002, a chemoprotectant/immunomodulator, added to first line carboplatin/paclitaxel in advanced non-small cell lung cancer (NSCLC): a randomized phase 1/2, open label, controlled study;Pazoles,2006
2. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines;Tew;Cancer Res,1988
3. Phase I study of continuous-infusion l-S, R-buthionine sulfoximine with intravenous melphalan;Bailey;J Natl Cancer Inst,1997
4. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid;O'Dwyer;Cancer Res,1991
5. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways;Ruscoe;J Pharmacol Exp Ther,2001